The University of Alabama at Birmingham Department of Obstetrics and Gynecology has enrolled the first patient in the United States in a Phase III clinical trial for a drug to treat preeclampsia in pregnant women that, if successful, would be a significant clinical breakthrough for reducing pre-term births and infant mortality
Read more: bit.ly/1nXlPbL
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?